key: cord-291590-24psoaer
authors: Ogando, Natacha S.; Zevenhoven-Dobbe, Jessika C.; Posthuma, Clara C.; Snijder, Eric J.
title: The enzymatic activity of the nsp14 exoribonuclease is critical for replication of Middle East respiratory syndrome-coronavirus
date: 2020-06-20
journal: bioRxiv
DOI: 10.1101/2020.06.19.162529
sha: 
doc_id: 291590
cord_uid: 24psoaer

Coronaviruses (CoVs) stand out for their large RNA genome and complex RNA-synthesizing machinery comprising 16 nonstructural proteins (nsps). The bifunctional nsp14 contains an N-terminal 3’-to-5’ exoribonuclease (ExoN) and a C-terminal N7-methyltransferase (N7-MTase) domain. While the latter presumably operates during viral mRNA capping, ExoN is thought to mediate proofreading during genome replication. In line with such a role, ExoN-knockout mutants of mouse hepatitis virus (MHV) and severe acute respiratory syndrome coronavirus (SARS-CoV) were previously found to have a crippled but viable hypermutation phenotype. Remarkably, using an identical reverse genetics approach, an extensive mutagenesis study revealed the corresponding ExoN-knockout mutants of another betacoronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), to be non-viable. This is in agreement with observations previously made for alpha- and gammacoronaviruses. Only a single MERS-CoV ExoN active site mutant could be recovered, likely because the introduced D191E substitution is highly conservative in nature. For 11 other MERS-CoV ExoN active site mutants, not a trace of RNA synthesis could be detected, unless – in some cases – reversion had first occurred. Subsequently, we expressed and purified recombinant MERS-CoV nsp14 and established in vitro assays for both its ExoN and N7-MTase activities. All ExoN knockout mutations that were lethal when tested via reverse genetics were found to severely decrease ExoN activity, while not affecting N7-MTase activity. Our study thus reveals an additional function for MERS-CoV nsp14 ExoN, which apparently is critical for primary viral RNA synthesis, thus differentiating it from the proofreading activity thought to boost long-term replication fidelity in MHV and SARS-CoV. Importance The bifunctional nsp14 subunit of the coronavirus replicase contains 3’-to-5’ exoribonuclease (ExoN) and N7-methyltransferase (N7-MTase) domains. For the betacoronaviruses MHV and SARS-CoV, the ExoN domain was reported to promote the fidelity of genome replication, presumably by mediating some form of proofreading. For these viruses, ExoN knockout mutants are alive while displaying an increased mutation frequency. Strikingly, we now established that the equivalent knockout mutants of MERS-CoV ExoN are non-viable and completely deficient in RNA synthesis, thus revealing an additional and more critical function of ExoN in coronavirus replication. Both enzymatic activities of (recombinant) MERS-CoV nsp14 were evaluated using newly developed in vitro assays that can be used to characterize these key replicative enzymes in more detail and explore their potential as target for antiviral drug development.

The bifunctional nsp14 subunit of the coronavirus replicase contains 3'-to-5' 58 exoribonuclease (ExoN) and N7-methyltransferase (N7-MTase) domains. For the 59 betacoronaviruses MHV and SARS-CoV, the ExoN domain was reported to promote 60 the fidelity of genome replication, presumably by mediating some form of proofreading.

For these viruses, ExoN knockout mutants are alive while displaying an increased 62 mutation frequency. Strikingly, we now established that the equivalent knockout 63 mutants of MERS-CoV ExoN are non-viable and completely deficient in RNA 64 synthesis, thus revealing an additional and more critical function of ExoN in coronavirus

Interestingly, a quite different phenotype was described for the corresponding ExoN-122 knockout mutants of two betacoronaviruses, mouse hepatitis virus (MHV) and CoV. While ExoN inactivation decreased replication fidelity in these viruses, conferring 124 a 'mutator phenotype', the mutants were viable, both in cell culture (22, 23) and in 125 animal models (24). These findings suggested that ExoN may indeed be part of an 126 error correction mechanism. Subsequently, the ability of ExoN to excise 3'-terminal 127 mismatched nucleotides from a double-stranded (ds) RNA substrate was 128 demonstrated in vitro using recombinant SARS-CoV nsp14 (25). Furthermore, this 129 activity was shown to be strongly enhanced (up to 35-fold) by the presence of nsp10, 130 a small upstream subunit of the CoV replicase (26). The two subunits were proposed 131 to operate, together with the nsp12-RdRp, in repairing mismatches that may be 132 introduced during CoV RNA synthesis (21, 27) . In cell culture, MHV and SARS-CoV 133 mutants lacking ExoN activity exhibit increased sensitivity to mutagenic agents like 5-134 fluoracil (5-FU), compounds to which the wild-type virus is relatively resistant (28, 29) . 135 Recently, ExoN activity was also implicated in CoV RNA recombination, as an MHV 136 ExoN knockout mutant exhibited altered recombination patterns, possibly reflecting its 137 involvement in other activities than error correction during CoV replication and 138 subgenomic mRNA synthesis (30). Outside the order Nidovirales, arenaviruses are the 139 only other RNA viruses known to employ an ExoN domain, which is part of the 140 arenavirus nucleoprotein and has been implicated in fidelity control (31) and/or immune 141 evasion, the latter by degrading viral dsRNA (32, 33) . Based on results obtained with 142 TGEV and MHV ExoN knockout mutants, also the CoV ExoN activity was suggested 143 to counteract innate responses (34, 35) . 144 In the meantime, CoV nsp14 was proven to be a bifunctional protein by the discovery 145 of an (N7-guanine)-methyltransferase (N7-MTase) activity in its C-terminal domain 146 (36) (Fig. 1 ). This enzymatic activity was further corroborated in vitro, using biochemical 147 assays with purified recombinant SARS-CoV nsp14. The enzyme was found capable 148 of methylating cap analogues or GTP substrates, in the presence of S-adenosyl 149 methionine (SAM) as methyl donor (36, 37) . The N7-MTase was postulated to be a 150 key factor for equipping CoV mRNAs with a functional 5'-terminal cap structure, as N7-151 methylation is essential for cap recognition by the cellular translation machinery (25). 152 Although, the characterization of the nsp14 N7-MTase active site and reaction 153 mechanism was not completed, alanine scanning mutagenesis and in vitro assays with 154 nsp14 highlighted several key residues ( Fig. 1) (36, 38, 39) . Moreover, crystal 155 structures of SARS-CoV nsp14 in complex with its nsp10 co-factor (PDB entries 5C8U 156 and 5NFY) revealed several unique structural and functional features (Ma et al., 2015;  157 Ferron et al., 2018) . These combined structural and biochemical studies confirmed that 158 the two enzymatic domains of nsp14 are functionally distinct (36) and physically 159 independent (20, 21). Still, the two activities are structurally intertwined, as it seems 160 that the N7-MTase activity depends on the integrity of the N-terminal ExoN domain, 161 whereas the flexibility of the protein is modulated by a hinge region connecting the two 162 domains (21). 163 Coronaviruses are abundantly present in mammalian reservoir species, including 164 bats, and pose a continuous zoonotic threat (40) (41) (42) (43) . To date, seven CoVs that can 165 infect humans have been identified, and among these the severe acute respiratory continues to circulate and cause serious human disease, primarily in the Arabian Peninsula (45) . Occasional spread to other countries has also occurred, including an 172 outbreak with 186 confirmed cases in South Korea in 2015 (46-48 viable, while displaying a 15-to 20-fold increased mutation rate (Eckerle, Lu et al. 2007 , 203 Eckerle, Becker et al. 2010 ). An alignment of CoV nsp14 amino acid sequences is 204 presented in Fig. 1 , including SARS-CoV-2, which emerged during the course of this 205 project. It highlights the key motifs/residues of the two enzymatic domains of nsp14, 206 as well as other structural elements, like the nsp10 binding site, the hinge region 207 connecting the ExoN and N7-MTase domains, and three previously identified zinc 208 finger domains (20, 21) . The alignment also illustrates the generally high degree of 209 nsp14 sequence conservation across different CoV (sub)genera.

In the present study, we targeted all five predicted active site residues of the MERS-

CoV ExoN domain (D90, E92, E191, D273, and H268) by replacing them with alanine 212 as well as more conservative substitutions (D to E or Q; E to D or Q) . This yielded a 213 total of 14 ExoN active site mutants ( Fig. 2A) Transcripts were electroporated into BHK-21 cells, which lack the DPP4 receptor 220 required for natural MERS-CoV infection (Chan, Chan et al. 2013 , Raj, Mou et al. 2013 but are commonly used to launch engineered CoV mutants because of their excellent 222 survival of the electroporation procedure (19, 22, 23, 34, 51, 54) . As BHK-21 cells have 223 a severely compromised innate immune response (55), they would seem an 224 appropriate cell line to launch ExoN knockout mutants also in case the enzyme would 225 be needed to counter innate immunity (Becares, Pascual-Iglesias et al. 2016 , Case, Li 226 et al. 2018 . To amplify any progeny virus released, transfected BHK-21 cells were 227 mixed with either innate immune-deficient (Vero) or -competent (HuH7) cells, which 228 both are naturally susceptible to MERS-CoV infection.

In stark contrast to what was previously described for MHV and SARS-CoV, 230 mutagenesis of ExoN active site residues was found to fully abrogate MERS-CoV 231 replication. When transfected cell cultures were analyzed using immunofluorescence 232 microscopy at 2 days post transfection (d p.t.), abundant signal was always observed 233 for wild-type MERS-CoV, but no sign of virus replication was observed for 13 out of 14 234 mutants tested (Fig. 2 ), regardless whether Vero or HUH7 cells were used for 235 propagation of recombinant virus. Furthermore, infectious progeny was not detected 236 when transfected cell culture supernatants were analyzed in plaque assays ( Fig. 2 and   237 data not shown). The single exception was the mutant carrying the conservative E191D 238 replacement in ExoN motif II (Fig. 1) , which was alive but somewhat crippled, as will 239 be discussed in more detail below. These results were consistent across a large The lack of MERS-CoV-specific RNA synthesis was further analyzed using RT-PCR 259 assays specifically detecting genomic RNA or subgenomic mRNA3. RNA specifying an A1235D substitution in the betacoronavirus-specific marker (βSM) 287 domain of nsp3, which has been predicted to be a non-enzymatic domain (58) and is 288 absent in alpha-and delta-coronaviruses (59, 60). Thus, we assumed that any 289 changes in viral replication were likely caused by the E191D mutation in nsp14 ExoN.

The same virus stock was used to assess growth kinetics in HuH7 cells (Fig. 4B ) and 291 Vero cells (Fig. 4A ), which were found to be very similar for wt and mutant virus. Still, 292 the E191D mutant was found to be somewhat crippled, yielding smaller plaque sizes 293 and somewhat lower progeny titers in HuH7 cells (Fig. 4 B-C), but not in Vero cells 294 (Fig. 4A ). 295 We next examined the sensitivity of E191D and wt virus to the mutagenic agent 5-296 FU, which intracellularly is converted into a nucleoside analogue that is incorporated 297 into viral RNA (61, 62). Previously, MHV and SARS-CoV ExoN knockout mutants were 298 found to exhibit increased sensitivity to 5-FU treatment, in particular in multi-cycle 299 experiments, which was attributed to a higher mutation frequency in the absence of 300 ExoN-driven error correction (28). We employed this same assay to assess the 301 phenotype of the E191D mutant in more detail, by performing plaque assays in HuH7 Previously, the ExoN activity of SARS-CoV nsp14 was found to be dramatically 366 stimulated by the addition of nsp10 as co-factor (26). Consequently, we also expressed 367 and purified MERS-CoV nsp10 and optimized the ExoN assay by testing different 368 molar ratios between nsp14 and nsp10 (Fig. 6A , left-hand side), different nsp14 369 concentrations (Fig. 6B , left-hand side), and by different incubation times (Fig. 7 , left-370 hand side). MERS-CoV nsp14 ExoN activity was found to be stimulated by nsp10 in a 371 dose-dependent manner (Fig. 6A) , while nsp10 did not exhibit any nuclease activity by 372 itself (Fig. 6B, nsp10 lane) . The full-length substrate is more completely degraded 373 when a fourfold (or higher) excess of nsp10 over nsp14 was used compared to the 374 effect of merely increasing the nsp14 concentration in the assay (Fig. 6B ). Similar (Bouvet, Imbert et al. 2012 , Ma, Wu et al. 2015 .

Using a 4:1 ratio of nsp10 versus nsp14, MERS-CoV ExoN activity was analyzed in 382 a time-course experiment, (Fig. 7) . Over time, the full-length substrate was 383 progressively converted to a set of degradation products in the size range of 6-18 nt. 384 We anticipated that the structure of the H4 RNA substrate would change from a 

When the two proteins were combined in the same reaction, a strong increase of ExoN 409 activity was observed for both nsp14-nsp10 pairs, with the SARS-CoV pair appearing 410 to be somewhat more processive than the MERS-CoV pair (Fig. 8, lanes 2 and 9) . (Fig. 2) . 434 We also evaluated the impact of the H229C ZF1 mutation, which -despite its 435 conservative nature -yielded a crippled mutant virus (Fig. 2) and of two N7-MTase 436 mutations (discussed below). The N7-MTase mutants displayed wt nsp14-like ExoN 437 activities (Fig. 9) , suggesting that -as in SARS-CoV nsp14 -ExoN and N7-MTase 438 activities are functionally separated (36). Analyzing the substrate degradation pattern 439 of the H229C mutant (Fig. 7) , the enzyme seems to be somewhat crippled when 440 compared to wt nsp14. This suggests that this mutation alters ExoN activity in vitro, 441 potentially by affecting the structure of the ExoN domain, as ZF1 is in close proximity of the nsp10 interaction surface (20). However, a similar reduction of ExoN activity was 443 observed for the E191D mutant (Fig. 7) , which was much more viable than the H229C Recombinant MERS-CoV nsp14 was found to methylate GpppA, but not m7GpppA 464 (Fig. 10A) , which yielded a signal that was similar to the background signal in assays 465 lacking nsp14 or substrate (data not shown). Methylation increased with time until 466 reaching a plateau after 120 min (Fig. 10B) . The N7-MTase activity of the various 467 nsp14 mutants was compared with that of wt nsp14 after reaction times of 30 and 120 468 min (Fig. 10C) . While the R310A and D331A control mutations fully inactivated the N7- ExoN catalytic residues abolished all detectable viral RNA synthesis (Fig. 3 ) and the 484 release of viral progeny (Fig. 2) . The only exception was the conservative E191D 485 mutant, which was found to exhibit near-wild-type levels of ExoN activity ( Fig. 7 and   486 9). Based on nsp14 conservation (Fig. 1 ) and the viable phenotype of SARS-CoV and 487 MHV ExoN-knockout mutants, MERS-CoV was expected to tolerate ExoN inactivation, 488 in particular since the enzyme was proposed to improve the fidelity of CoV replication 489 without being essential for RNA synthesis per se (10, 14, 21-23, 26, 29) . This notion is 

In the only viable MERS-CoV ExoN active site mutant obtained, E191D, the catalytic 545 motif was changed from DEEDh to the DEDDh that is characteristic of all members of 546 the exonuclease family that ExoN belongs to (14, 15, 75) . The phenotype of the E191D 547 virus mutant was comparable to that of wt virus (Fig. 4) . Biochemical assays revealed 548 that E191D-ExoN enzyme is able to hydrolyze a dsRNA substrate with an activity level 549 approaching that of the wt protein (Fig. 9) . Additionally, the E191D mutant behaved In this study, we developed an in vitro assay to evaluate MERS-CoV ExoN activity 554 using a largely double-stranded RNA substrate ( Fig. 6 and 7) . As previously observed is interchangeable between CoV subgenera in its role as co-factor for the nsp16 2′-O-565 methyltransferase, which was attributed to the high level of conservation of the nsp10-566 nsp16 interaction surface (77). As nsp14 and nsp16 share a common interaction 567 surface on nsp10 (21, 26, 66), we explored whether a similar co-factor exchange was 568 possible in the context of nsp14's ExoN activity, which was indeed found to be the case 569 (Fig. 8) . Structurally, nsp14 interacts with nsp10 figuratively similar to a "hand (nsp14) 570 over fist (nsp10)" conformation (21). In the formation of this complex, nsp10 induces 571 conformational changes in the N-terminal region of ExoN that adjusts the distance 572 between the catalytic residues in the back of the nsp14 palm and, consequently, impact 573 ExoN activity (21). The exchange of the nsp10 co-factor between the two beta-CoVs 9), indicating that each of these residues is important for catalysis.

Our study suggests that, in addition to the active site residues, also other motifs in 589 MERS-CoV ExoN are important for virus viability, specifically the two ZF motifs that 590 were probed using two point mutations each (Fig. 2A) . In previous ZF1 studies, a 591 mutation equivalent to H229A created solubility issues during expression of recombinant SARS-CoV nsp14 (20) and resulted in a partially active ExoN in the case 593 of white bream virus, a torovirus that also belongs to the nidovirus order (79). It was 594 suggested that ZF1 contributes to the structural stability of ExoN, as it is close to the 595 surface that interacts with nsp10 (20). Here, we demonstrate that the more 596 conservative H229C replacement, which converts ZF1 from a non-classical CCCH 597 type ZF motif into a classical CCCC type (63), was tolerated during recombinant protein 598 expression and yielded an ExoN that is quite active in vitro (Fig. 7) . This likely 599 contributed to the fact that the H229C virus mutant retained a low level of viability ( Fig.   600 2), although its overall crippled phenotype and the non-viable phenotype of mutant 601 C201H clearly highlight the general importance of ZF1 for virus replication. In contrast, 602 the corresponding TGEV mutant (ZF-C) was not strongly affected and could be stably 

Quasispecies diversity 879 determines pathogenesis through cooperative interactions in a viral population

The hypercycle. A principle of natural self-organization. Part A: 882 Emergence of the hypercycle

Viral quasispecies evolution

Mutational fitness effects in RNA and single-stranded DNA viruses: common 886 patterns revealed by site-directed mutagenesis studies

Viral mutation rates

Lack of evidence for proofreading mechanisms 891 associated with an RNA virus polymerase

Mutation rates among RNA viruses

Error catastrophe and antiviral strategy

Selforganization of matter and the evolution of biological macromolecules

Discovery of the first 899 insect nidovirus, a missing evolutionary link in the emergence of the largest RNA virus 900 genomes

The 902 footprint of genome architecture in the largest genome expansion in RNA viruses

A planarian 905 nidovirus expands the limits of RNA genome size

Description and 907 initial characterization of metatranscriptomic nidovirus-like genomes from the proposed new 908 family Abyssoviridae, and from a sister group to the Coronavirinae, the proposed genus 909 Alphaletovirus

Unique and conserved features of genome and proteome of SARS-912 coronavirus, an early split-off from the coronavirus group 2 lineage

Exoribonuclease superfamilies: structural analysis and 914 phylogenetic distribution

Purification and characterization of Escherichia coli RNase 916 T

Structural basis for the 3'-5' exonuclease activity of Escherichia coli 918 DNA polymerase I: a two metal ion mechanism

A general two-metal-ion mechanism for catalytic RNA

922 Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA 923 synthesis

Structural basis 925 and functional analysis of the SARS coronavirus nsp14-nsp10 complex

Structural and molecular basis of mismatch correction 929 and ribavirin excision from coronavirus RNA

High fidelity of murine hepatitis virus 931 replication is decreased in nsp14 exoribonuclease mutants

Infidelity of SARS-CoV Nsp14-exonuclease mutant 934 virus replication is revealed by complete genome sequencing

A live, impaired-936 fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal 937 disease

In vitro 939 reconstitution of SARS-coronavirus mRNA cap methylation

RNA 3'-end mismatch 941 excision by the severe acute respiratory syndrome coronavirus nonstructural protein 942 nsp10/nsp14 exoribonuclease complex

One severe acute respiratory syndrome coronavirus protein 945 complex integrates processive RNA polymerase and exonuclease activities

Coronaviruses lacking 948 exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading 949 and potential therapeutics

Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of 952 Exoribonuclease-Inactivating Mutations

Routh 954 AL, Denison MR. 2020. The coronavirus proofreading exoribonuclease mediates extensive 955 viral recombination

Arenaviridae exoribonuclease presents genomic RNA edition capacity

Structure of the Lassa 960 virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for 961 immune suppression

The exonuclease domain of Lassa virus 963 nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses

Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response

Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate 970 Immunity

Functional screen reveals SARS 972 coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase

975 Characterization of the guanine-N7 methyltransferase activity of coronavirus nsp14 on 976 nucleotide GTP

Structure-978 function analysis of severe acute respiratory syndrome coronavirus RNA cap guanine-N7-979 methyltransferase

Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates 982

Differing Requirements for Genome Translation and Resistance to Innate Immunity

Bat origin of a new human coronavirus: there and back 985 again

Identification of new human coronaviruses

A Novel Coronavirus 989 Emerging in China -Key Questions for Impact Assessment

A pneumonia outbreak 993 associated with a new coronavirus of probable bat origin

Isolation of a 995 novel coronavirus from a man with pneumonia in Saudi Arabia

Spread, circulation, and evolution of the 999 Middle East respiratory syndrome coronavirus. mBio 5

Dynamics of scientific publications 1001 on the MERS-CoV outbreaks in Saudi Arabia

Drivers of MERS-CoV Emergence in 1004 Qatar

Drivers of MERS-CoV transmission: what do we know?

Additional changes to taxonomy ratified in a special vote by the International Committee on 1011 Taxonomy of Viruses

Coronaviridae Study Group of the International Committee on Taxonomy of V. 2020. The 1013 species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and 1014 naming it SARS-CoV-2

Engineering a replication-competent, propagation-defective Middle East 1017 respiratory syndrome coronavirus as a vaccine candidate

Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses

Genomic characterization of a 1024 newly discovered coronavirus associated with acute respiratory distress syndrome in 1025 humans

Effects of mutagenesis of 1027 murine hepatitis virus nsp1 and nsp14 on replication in culture

T7 RNA polymerase-dependent and -1029 independent systems for cDNA-based rescue of Rift Valley fever virus

A conserved 3'----5' exonuclease 1032 active site in prokaryotic and eukaryotic DNA polymerases

The Curious Case 1034 of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity

Proteomics analysis 1038 unravels the functional repertoire of coronavirus nonstructural protein 3

Bioinformatics and functional analyses of coronavirus nonstructural 1040 proteins involved in the formation of replicative organelles

Nsp3 of coronaviruses: Structures and functions of a large 1042 multi-domain protein

5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate 1045 synthase inhibition of human colorectal cancers

Effect of 5-fluorouracil combination therapy on RNA 1047 processing in human colonic carcinoma cells

Zinc finger domains as therapeutic targets for metal-based compounds 1049 -an update

Zn(II) binding 1051 and DNA binding properties of ligand-substituted CXHH-type zinc finger proteins

Biochemical characterization of 1054 exoribonuclease encoded by SARS coronavirus

Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes

The crystal 1061 structure of nsp10-nsp16 heterodimer from SARS-CoV-2 in complex with S-1062 adenosylmethionine

Alisporivir inhibits MERS-and SARS-1065 coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model

MERS-coronavirus replication induces severe in vitro cytopathology and is strongly 1070 inhibited by cyclosporin A or interferon-alpha treatment

SARS-coronavirus-2 1073 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

Fitness Barriers Limit 1076 Reversion of a Proofreading-Deficient Coronavirus

Structure of the SARS-CoV nsp12 polymerase bound to 1078 nsp7 and nsp8 co-factors

2020. 1081 Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by 1082 remdesivir

Structure of 1084 replicating SARS-CoV-2 polymerase

The 3'-5' exonuclease site of DNA 1086 polymerase III from gram-positive bacteria: definition of a novel motif structure

Genome-wide analysis of protein-protein interactions and involvement of viral proteins in 1090 SARS-CoV replication

Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In 1093 Vitro and In Vivo To Reduce Replication and Pathogenesis

The 3'-5' exonuclease of DNA polymerase I of 1095

Escherichia coli: contribution of each amino acid at the active site to the reaction

Characterization of a 1098 bafinivirus exoribonuclease activity

To sense or not to sense viral RNA--essentials of coronavirus innate 1100 immune evasion

SARS-coronavirus replication is supported by a reticulovesicular 1103 network of modified endoplasmic reticulum

2020. A unifying structural and functional model of the coronavirus 1106 replication organelle: Tracking down RNA synthesis

Characterization of Bafinivirus main protease 1108 autoprocessing activities

The Nonstructural Proteins Directing Coronavirus RNA 1110 Synthesis and Processing

Arterivirus Nsp1 modulates the 1112 accumulation of minus-strand templates to control the relative abundance of viral mRNAs

En passant mutagenesis: a two step markerless 1115 red recombination system

Double-stranded RNA is 1117 produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by 1118 negative-strand RNA viruses

Ultrastructure and origin of membrane vesicles associated with the 1121 severe acute respiratory syndrome coronavirus replication complex

Reverse genetics of SARS-related 1124 coronavirus using vaccinia virus-based recombination

New low-viscosity overlay 1126 medium for viral plaque assays

CoV forms an ion channel: experiments and molecular dynamics simulations

Toward the identification of viral 1132 cap-methyltransferase inhibitors by fluorescence screening assay

Fast, scalable generation of high-quality protein 1135 multiple sequence alignments using Clustal Omega

Jalview Version 2--a 1137 multiple sequence alignment editor and analysis workbench